Reduce ALT and AST activities, inhibit NF-κB binding activity, down-regulate smurf2 gene expression, apply to CHC patients and prevent hepatocarcinoma in patients with HCV-associated cirrhosis. The gene discussed is NFKB1; the disease is cryohydrocytosis.